DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Open Access
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 283, 74-85
- https://doi.org/10.1016/j.jneuroim.2015.04.006
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during InflammationJournal of Biological Chemistry, 2014
- Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAEJournal of Clinical Investigation, 2014
- BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safetyCurrent Medical Research and Opinion, 2013
- Detection of fumarate–glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolismArchives of Dermatological Research, 2013
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple SclerosisNew England Journal of Medicine, 2012
- Effects of dimethyl fumarate on neuroprotection and immunomodulationJournal of Neuroinflammation, 2012
- Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent MechanismsArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Dimethyl Fumarate, an Immune Modulator and Inducer of the Antioxidant Response, Suppresses HIV Replication and Macrophage-Mediated Neurotoxicity: A Novel Candidate for HIV NeuroprotectionThe Journal of Immunology, 2011
- Chemical target and pathway toxicity mechanisms defined in primary human cell systemsJournal of Pharmacological and Toxicological Methods, 2009
- Characterization of compound mechanisms and secondary activities by BioMAP analysisJournal of Pharmacological and Toxicological Methods, 2006